Meeting of the Advisory Commission on Childhood Vaccines, 36805 [2017-16582]

Agencies

• DEPARTMENT OF HEALTH AND HUMAN SERVICES
• Health Resources and Services Administration

[Federal Register Volume 82, Number 150 (Monday, August 7, 2017)]
[Notices]
[Page 36805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16582]



[[Page 36805]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act, notice is hereby given that a meeting is scheduled for 
the Advisory Commission on Childhood Vaccines (ACCV). This meeting will 
be open to the public. Information about the ACCV and the agenda for 
this meeting can be obtained by accessing the following Web site: 
https://www.hrsa.gov/advisorycommittees/childhoodvaccines/.

DATES: The meeting will be held on September 8, 2017, at 10:00 a.m. 
EDT.

ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, 
MD, Conference Room 5N54. The public can join the meeting by:
    1. (In Person) Persons interested in attending the meeting in 
person are encouraged to submit a written notification to: Annie 
Herzog, Division of Injury Compensation Programs (DICP), Healthcare 
Systems Bureau (HSB), HRSA, Rm. 8N146B, 5600 Fishers Lane, Rockville, 
Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is held 
in a federal government building, attendees will need to go through a 
security check to enter the building and participate in the meeting. 
This written notification is encouraged so that a list of attendees can 
be provided to make entry through security quicker. Persons may attend 
in person without providing written notification, but their entry into 
the building may be delayed due to security checks and the requirement 
to be escorted to the meeting by a federal government employee. To 
request an escort to the meeting after entering the building, call 
Amber Johnson at (301) 443-0129.
    2. (Audio Portion) Call the conference phone number (800) 369-1833 
and providing the following information:
    Leader Name: Dr. Narayan Nair
    Password: 6706374
    3. (Visual Portion) Connect to the ACCV Adobe Connect Pro Meeting 
using the following URL: https://hrsa.connectsolutions.com/accv/. 
Participants should call and connect 15 minutes prior to the meeting to 
allow time for the logistics to be set-up. If you have never attended 
an Adobe Connect meeting, please test your connection using the 
following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm.
    Get a quick overview of the software at: https://www.adobe.com/go/connectpro_overview.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, 
HRSA in one of three ways: (1) Send a request to the following address: 
Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 8N146B, 
Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) send an 
email to aherzog@hrsa.gov.
    The ACCV will meet on Friday, September 8, 2017, beginning at 10:00 
a.m. in the 5600 Fishers Lane Building, Rockville, Maryland 20857; 
however, meeting times and locations could change. For the latest 
information regarding meeting start time and location, please check the 
ACCV Web site: https://www.hrsa.gov/advisorycommittees/childhoodvaccines/.

SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of 
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as 
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, 
and advises the Secretary of HHS (the Secretary) on issues related to 
implementation of the National Vaccine Injury Compensation Program 
(VICP).
    Activities of the ACCV also include: Recommending changes to the 
Vaccine Injury Table on its own initiative or as the result of the 
filing of a petition; advising the Secretary in implementing section 
2127 of the Act regarding the need for childhood vaccination products 
that result in fewer or no significant adverse reactions; surveying 
federal, state, and local programs and activities related to gathering 
information on injuries associated with the administration of childhood 
vaccines, including the adverse reaction reporting requirements of 
section 2125(b) of the Act; advising the Secretary on the methods of 
obtaining, compiling, publishing, and using credible data related to 
the frequency and severity of adverse reactions associated with 
childhood vaccines; consulting on the development or revision of 
Vaccine Information Statements; and recommending to the Director of the 
National Vaccine Program research related to vaccine injuries which 
should be conducted to carry out the VICP.
    The agenda items for the meeting will include, but are not limited 
to, updates from DICP, Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health) and Center for Biologics, Evaluation 
and Research (Food and Drug Administration). A draft agenda and 
additional meeting materials will be posted on the ACCV Web site 
(https://www.hrsa.gov/advisorycommittees/childhoodvaccines/) 
prior to the meeting. Agenda items are subject to change as priorities 
dictate.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the ACCV should be sent to Annie Herzog 
using the address and phone number above by September 4, 2017. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Annie Herzog, using the address and phone number above at least 
10 days prior to the meeting.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2017-16582 Filed 8-4-17; 8:45 am]
 BILLING CODE 4165-15-P